Societe Generale Effekten (S28250) ニュース

That deal with msft could double stock prices from here, target $60, IMO

Some valid points, some not so valid sweeping generalizations and misrepresentations. Missing is any acknowledgement that the economy as a WHOLE is doing fine, and inflation is down. Some of the comments place matters in better context.

I had been missing Brian Williams since he left

gtsm not gonna buy your shares either stay there or whack it out your choice

Hope everyone is finally ready for liftoff soon lol imo

BOOM it's going to be epic when the dust settles and clears away revealing a diamond....in RDGL AND ISOPET

why would you summon donkey #2

MODERATE Fred.

Does anyone have info on

the OTC Markets report that shows the Jason Black 2014 transaction?

$ILLR is consolidating at strong support levels, and technical indicators are signaling a potential breakout. Combine this with their growth in key sectors, and you have an ideal buy opportunity. 🚀

rrrr panic posting siempre. is there any other kinda dd aqui?

A little healthy retrace earlier today but Friday's have been a bit odd the past few months. It seems to spike a little going into the weekend after the stock market closes. I don't know why but that has been the trend.

I expect $100,000 to be a strong psychological resistance I cou

Like a gold ring in a pig's snout is a beautiful woman who shows no discretion.
—Proverbs 11:22

he probably meant "if" they extinguish all debt

Are you upset you did not buy any .03's now? It's not my fault. You were warned she was going to bounce. 😃 LMAO

" There is that reading comprehension problem again.
I don’t buy self enrichment scams for the 1142nd time "

For the 1142 time I'm asking for y

The website is going live today

we all do

I have you beat, lol

And still Merck didn't loan $10M to NWBO so that they didn't have to sell shares for Pennies
Yep makes perfect sense 

"and called out that no one is talking about a phase 2/3 alzheimers drug going for EMA approval."

Few seem to be aware that Donnanemab was almost approved via accelerated pathway based on a phase 2 trial. The CRL merely said they would need to show 100 patients on drug for 1 year for

We need your analysis, most respected trader. Perhaps cousin Arnold could even chime in. 

You will probably get $.40 per share next week if you wait lol 

4 billion AS, is all you need to know. I said it too to OS.

Definitely a good update!

Management to push the boundaries of what is possible, ultimately driving sustainable change in the industry.
SGTM

Nvidia needs a good PR company specifically one that understands what makes stocks move. There were two major issues in the Q conference which caused the higher short volume and continuing the large swings.
CFO stating 70% would be their low range. Well let's take a look at some other GP's.